Skip to content

Is There an Ideal Dose of Intravenous Fentanyl in the Prehospital Setting

Is There an Ideal Dose of Intravenous Fentanyl in the Prehospital Setting: A Prospective Cluster-randomized Comparison of 2 vs. 3 μg/kg/Transport

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02914678
Enrollment
7093
Registered
2016-09-26
Start date
2016-10-31
Completion date
2017-10-31
Last updated
2017-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain

Keywords

Emergency Medical Services, Analgesics

Brief summary

In a previous study the investigators evaluated the apparent efficacy and safety of intravenous fentanyl administered by ambulance personnel and found that 58.4% (CI 56.4-60.4) out of 2348 prehospital patients treated with fentanyl still experienced moderate to severe pain \[numeric rating scale (NRS, 0-10) \> 3\] at hospital arrival. The number of patients with possible fentanyl-related side effects was low. Therefore, the aim of the present study is to explore the efficacy and safety of a liberalized pain treatment protocol for ambulance personnel (a total of 3 μg/kg per transport) compared with existing restrictive protocol (a total of 2 μg/kg per transport). The investigators hypothesize that: * A higher proportion of patients will experience sufficient pain relief at hospital admission (NRS \< 4) using the liberalized protocol and * There will be no differences in the proportion of potential fentanyl related side-effects are observed.

Detailed description

A prospective cluster-randomized trial observing proportional differences in sufficient pain relief at hospital admission (NRS \< 4) and potential fentanyl related side-effects between patients treated by ambulance personnel applying either: * a more liberal treatment approach (a total of 3 μg/kg per transport) or * existing treatment approach (a total of 2 μg/kg per transport). The Ambulance stations and their affiliated ambulance personnel are stratified into 5 clusters according to size/average transports per month and randomized to either liberal or existing treatment approach within each cluster. As patients are not randomized on an individual level baseline differences between the two groups and its patients are adjusted statistically with relevant confounders on 3 overall levels: 1. Patients: Charlson Comorbidity Index Score, main overall diagnose category, inhospital surrogate measures of disease severity (intensive care unit admission and 30-day mortality). 2. Ambulance personnel: Years of experience and preinterventional cumulative fentanyl administration and 3. Ambulance stations and geographical factors: prehospital time measures and geographical distance from site of emergency to hospital. These covariates are obtained from the Danish National Patient Registry, the Danish Civil Registration System and the electronic prehospital patient journal.

Interventions

OTHERFentanyl

Change in protocol from 2 to a total of 3 μg/kg fentanyl per transport

Sponsors

Central Denmark Region
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 110 Years
Healthy volunteers
No

Inclusion criteria

* Patients with acute pain treated with intravenous fentanyl by ambulance personnel

Exclusion criteria

* Reduced conscious level (GCS \< 15) before initiation of fentanyl treatment * Reduced respiratory rate (\< 10/minute) before initiation of fentanyl treatment * Patient weight \< 30 kg * Known opioid allergy * Women in labour * Chronic pain conditions

Design outcomes

Primary

MeasureTime frame
Proportion of patients with sufficient pain relief (NRS < 4) at hospital arrivalUp to 6 hours

Secondary

MeasureTime frameDescription
Proportion of patients with reduced Glasgow Coma Scale (<15) after fentanyl administration and at any given point during transportUp to 6 hours
Proportion of patients with reduced respiratory rate (<10/minute) after fentanyl administration and at any given point during transportUp to 6 hours
Proportion of patients with reduced peripheral oxygen saturation (< 90%) after fentanyl administration and at any given point during transportUp to 6 hours
Proportion of patients with hypotension after fentanyl administration and at any given point during transportUp to 6 hoursHypotension defined as a drop in mean arterial pressure (MAP) \>= 10 mmHg to a MAP \< 70 mmHg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026